• Facebook
  • Rss
  • Twitter
  • Youtube
  • Store
  • Donate
NCCS - National Coalition for Cancer Survivorship
  • About
    • Our Mission
    • Our History
    • Our Leadership
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State Based Cancer Advocacy
  • Resources
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • COVID-19 Resources for Cancer Survivors
    • Order Our Resources
  • News
    • Cancer Convos Podcast
  • Events
    • Ellen L. Stovall Award
      • 2020 Stovall Awards
      • Honorees
      • Sponsors
      • Committees
      • Reception
      • Nominations
    • Cancer Policy Roundtable
      • Fall 2020 Cancer Policy Roundtable
      • Spring 2020 Cancer Policy Roundtable
    • Cancer Policy and Advocacy Team (CPAT) Symposium 2020
    • Webinars
  • Contact Us
  • Search
  • Menu Menu
  • 0Shopping Cart

Year-End MATCH (DEADLINE Dec 31): Donate & Make a Difference | Donate

FacebookProfile3

Guest Post Series: NCCS CEO Shelley Fuld Nasso Offers Advocate’s Perspective on Oncology Care Model

July 29, 2015/in Cancer News, Cancer Policy Blog Access to Care, Care Planning, Health Care Coverage, Payment Reform, Quality Cancer Care NCCS News /by actualize

The Centers for Medicare and Medicaid Services (CMS) recently announced the Oncology Care Model, a new payment model for physician practices administering chemotherapy that aims to provide higher quality, more highly coordinated oncology care at a lower cost to Medicare. This week, we’re presenting several different perspectives on the Oncology Care Model and how it will impact patients, providers, and cancer therapies. Be sure to read the perspectives from Dr. Michael Ybarra, Senior Director, Alliance Development, PhRMA and oncologist Dr. John Cox. 


This month marks the 50th anniversary of the Medicare program. There has been significant press coverage of the Medicare program over the last 50 years, and a study published in JAMA yesterday reported strong improvements in care for Medicare beneficiaries in a number of areas.

Reception shelley

Post by NCCS CEO Shelley Fuld Nasso, MPP (pictured at 2014 NCCS event)

Given that half of all cancer diagnoses are in individuals age 65 or over, the Medicare program is critical to the delivery of quality cancer care for Americans with cancer. However, the current fee-for-service does not promote patient-centered, well-coordinated care, as Dr. John Cox eloquently described in his recent blog post.

We believe that it is essential to change the way we deliver care to cancer patients, and in particular, to improve the doctor-patient discussion about treatment options to ensure that patients’ needs, values, and preferences are considered in decision-making. In order to change delivery, we must change the way we pay for care.

NCCS has long advocated for a thorough, patient-centered cancer care planning process, at diagnosis and at major transition points in care, including the transition to survivorship. Patients need and deserve a care plan that outlines their treatment and post-treatment care. It’s not about checking a box that a piece of paper was handed to a patient – it’s about truly engaging patients in decision-making about their care; ensuring that they are informed about their treatment options, including both benefits and risks of treatment; and respecting their autonomy to be involved in decisions to the degree they wish to participate.

“The Oncology Care Model (OCM) begins to address these disincentives in the system by encouraging practices to transform the way they deliver care to be more patient-centered.”
In order to deliver this kind of care, physicians need time to spend with their patients. If you ask patients what they want and need from their care, and how they define quality care, they want TIME with their care team. They want to be seen as a person, not a tumor or a diagnosis or a case. The current system does not support this kind of care delivery. In fact, it provides strong disincentives for physicians to spend the kind of time that individuals facing cancer need during the most difficult time in their lives.

The Oncology Care Model (OCM) begins to address these disincentives in the system by encouraging practices to transform the way they deliver care to be more patient-centered. Key elements include the requirements for care planning, 24/7 access to physicians, and care coordination and navigation. It is not a perfect model, but it’s an important start. NCCS has been outspoken in providing a patient perspective on this important proposal and has shared comments with the Center for Medicare and Medicaid Innovation (CMMI).

We believe the OCM holds significant promise of boosting patient satisfaction and improving the overall quality of care, and we look forward to continuing to engage with CMMI through the implementation and evaluation of the model, so that we can learn from it and help disseminate the best practices and lessons learned.

As we celebrate 50 years of Medicare, we must not lose sight of the need to improve the way we care for our nation’s seniors with cancer.

Tags: cancer care, Cancer Survivorship, care planning, Medicare, Oncology Care Model, quality
Share this entry
  • Share on Facebook
  • Share on Twitter
https://canceradvocacy.org/wp-content/uploads/2014/06/FacebookProfile3.png 280 280 actualize https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png actualize2015-07-29 16:34:562015-07-29 16:34:56Guest Post Series: NCCS CEO Shelley Fuld Nasso Offers Advocate’s Perspective on Oncology Care Model
You might also like
NCCS Starburst 250px Health Care Roundup: Executive Order on Price Transparency; Coping with Cancer; New Data on Cancer Disparities; US Health Spending; More
Dome Thumbnail Shelley Fuld Nasso Joins NCCS as Director of Public Policy
ProtectOurCare 1024px ACA Update April 6, 2018 | New Iowa Law Allows Health Plans That Exclude Preexisting Condition Protections
DistressThumbnail Guest Post: Timing, Tools, Evaluation, and Documentation: Implementing Screening Programs for Psychosocial Distress
Stovall Award sq Logo Bl Ribbon NCCS Announces Winners of the 2018 Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care
NCCS Starburst Thumbnail WCOE: Pace of FDA Drug Approvals, Redesigning Insurance Exchanges, Shared Decision Making, and Thoughts on Data Collection
NCCS Starburst 250px Bill calling for written care plans for cancer patients introduced in Congress
NCCS Starburst 250px Cancer Policy News Roundup: Proposed Cuts to CHIP, Association Health Plans in Farm Bill, Prescribing Exercise for Cancer Patients, and More

Latest News

Canceradvocacy org default image

National Quality Forum Names NCCS CEO Shelley Fuld Nasso to 2021 Leadership Consortium Roster

February 24, 2021
NOTE: This press release was originally published on the National Quality Forum (NQF)…
Read more
https://canceradvocacy.org/wp-content/uploads/2019/10/Canceradvocacy-org-default-image.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2021-02-24 21:01:392021-02-24 21:01:39National Quality Forum Names NCCS CEO Shelley Fuld Nasso to 2021 Leadership Consortium Roster
HHS Humphrey bldg 1200

NCCS and Other Cancer Groups Urge HHS to Keep Six Protected Classes in Medicare Part D Drug Plans

February 19, 2021
The National Coalition for Cancer Survivorship (NCCS) joined with the Cancer Leadership…
Read more
https://canceradvocacy.org/wp-content/uploads/2017/10/HHS-Humphrey-bldg-1200.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2021-02-19 15:06:392021-02-24 19:29:10NCCS and Other Cancer Groups Urge HHS to Keep Six Protected Classes in Medicare Part D Drug Plans

NCCS Urges CDC Committee to Include Cancer Survivors in High-Risk Category for COVID-19 Vaccine Distribution

January 28, 2021
In a letter to the CDC’s Advisory Committee on Immunization Practices (ACIP), NCCS…
Read more
https://canceradvocacy.org/wp-content/uploads/CDC-Website.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2021-01-28 22:34:532021-01-28 22:42:08NCCS Urges CDC Committee to Include Cancer Survivors in High-Risk Category for COVID-19 Vaccine Distribution

Take Action

Stovall Award

The Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care is a unique opportunity for patients and survivors to recognize pioneers who are transforming the cancer care system.

Join CPAT

The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.

Share Your Story

NCCS represents the millions of Americans who share a common experience – the survivorship experience – living with, through and beyond a cancer diagnosis.

STAY CONNECTED

Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action

  • About
    • Our Mission
    • Our History
    • Our Leadership
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State Based Cancer Advocacy
  • Resources
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • COVID-19 Resources for Cancer Survivors
    • Order Our Resources
  • News
    • Cancer Convos Podcast
  • Events
    • Ellen L. Stovall Award
      • 2020 Stovall Awards
      • Honorees
      • Sponsors
      • Committees
      • Reception
      • Nominations
    • Cancer Policy Roundtable
      • Fall 2020 Cancer Policy Roundtable
      • Spring 2020 Cancer Policy Roundtable
    • Cancer Policy and Advocacy Team (CPAT) Symposium 2020
    • Webinars
  • Contact Us

National Coalition for Cancer Survivorship
8455 Colesville Road  |  Suite 930  |  Silver Spring, MD 20910
877-NCCS-YES  |  info@canceradvocacy.org
Privacy Policy  |  Terms and Conditions

Copyright © 1995-2021 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.

Video Post: Cancer Patients and Survivors Describe Quality Cancer Care Courage Carries Hope Fotolia 73341760 S Guest Post Series: Dr. Michael Ybarra Offers Innovator Perspective on Oncology...
Scroll to top

Harmar Brereton, MD

Founder
Northeast Regional Cancer Institute

 

“Perhaps one of the most impactful collaborations in Dr. Brereton’s extraordinary career remains his early work and long friendship with Ellen Stovall. Through him, and in turn through the thousands of lives he has touched, Ellen’s work continues, and her mission lives on.”

—Karen M. Saunders
President, Northeast Regional Cancer Institute